These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38997548)

  • 21. Physiologically Based Pharmacokinetic Modeling Approach to Identify the Drug-Drug Interaction Mechanism of Nifedipine and a Proton Pump Inhibitor, Omeprazole.
    Le Merdy M; Tan ML; Sun D; Ni Z; Lee SC; Babiskin A; Zhao L
    Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):41-51. PubMed ID: 33064292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the Impact of Drug Crystallinity in Amorphous Tacrolimus Capsules on Pharmacokinetics and Bioequivalence Using Discriminatory In Vitro Dissolution Testing and Physiologically Based Pharmacokinetic Modeling and Simulation.
    Purohit HS; Trasi NS; Sun DD; Chow ECY; Wen H; Zhang X; Gao Y; Taylor LS
    J Pharm Sci; 2018 May; 107(5):1330-1341. PubMed ID: 29289674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of fasted and fed bioequivalence for immediate release drug products using physiologically based biopharmaceutics modeling (PBBM).
    Jereb R; Kristl A; Mitra A
    Eur J Pharm Sci; 2020 Dec; 155():105554. PubMed ID: 32946959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drug.
    Danielak D; Paszkowska J; Staniszewska M; Garbacz G; Terlecka A; Kubiak B; Romański M
    Eur J Pharm Biopharm; 2023 May; 186():132-143. PubMed ID: 37015321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the composition of a fixed dose combination on bioequivalence results.
    Šalandová J; Franc A; Hofmann J; Dumicic A; Kukačková L; Červená T; Beránek J; Srbek J; Repický A; Vladovičová B; Vetchý D
    Int J Pharm; 2018 Jul; 546(1-2):235-246. PubMed ID: 29758343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Has the Time Come to Employ Population and Individual Bioequivalence for the Evaluation of Generics?
    Micheal F; Sayana M; Prasad R; Motilal BM
    Curr Drug Metab; 2020; 21(2):112-125. PubMed ID: 32234000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically based pharmacokinetic modeling and simulations to inform dissolution specifications and clinical relevance of release rates on elagolix exposure.
    Mukherjee D; Chiney MS; Shao X; Ju TR; Shebley M; Marroum P
    Biopharm Drug Dispos; 2022 Jun; 43(3):98-107. PubMed ID: 35405765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acalabrutinib Maleate Tablets: The Physiologically Based Biopharmaceutics Model behind the Drug Product Dissolution Specification.
    Pepin X; McAlpine V; Moir A; Mann J
    Mol Pharm; 2023 Apr; 20(4):2181-2193. PubMed ID: 36859819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation-dependent effect of achlorhydria.
    Doki K; Darwich AS; Patel N; Rostami-Hodjegan A
    Eur J Pharm Sci; 2017 Nov; 109():111-120. PubMed ID: 28774813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid self-nanoemulsifying drug delivery system filled in enteric coated hard gelatin capsules for enhancing solubility and stability of omeprazole hydrochloride.
    Al-Nimry SS; Alkhamis KA; Altaani BM
    Pharm Dev Technol; 2020 Jun; 25(5):588-600. PubMed ID: 31976799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologically Based Absorption Modelling to Explore the Formulation and Gastric pH Changes on the Pharmacokinetics of Acalabrutinib.
    Zhou D; Chen B; Sharma S; Tang W; Pepin X
    Pharm Res; 2023 Feb; 40(2):375-386. PubMed ID: 35478298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence evaluation of two omeprazole enteric-coated formulations in humans.
    Farinha A; Bica A; Pais JP; Toscano MC; Tavares P
    Eur J Pharm Sci; 1999 Mar; 7(4):311-5. PubMed ID: 9971914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a New Bioequivalent Omeprazole Product.
    Kumisbek G; Vetchý D; Kadyrbay A
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541153
    [No Abstract]   [Full Text] [Related]  

  • 35. Predicting Pharmacokinetics of Multisource Acyclovir Oral Products Through Physiologically Based Biopharmaceutics Modeling.
    García MA; Bolger MB; Suarez-Sharp S; Langguth P
    J Pharm Sci; 2022 Jan; 111(1):262-273. PubMed ID: 34678271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bioequivalence study of two omeprazole formulations in healthy male volunteers.
    Kim YK; Yoon S; Yu KS; Kim BH; Yim SV
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):928-934. PubMed ID: 27615007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishing the Safe Space via Physiologically Based Biopharmaceutics Modeling. Case Study: Fevipiprant/QAW039.
    Kourentas A; Gajewska M; Lin W; Dhareshwar SS; Steib-Lauer C; Kulkarni S; Hirsch S; Heimbach T; Mueller-Zsigmondy M
    AAPS J; 2023 Feb; 25(1):25. PubMed ID: 36788163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a clinically relevant specification for dissolution testing using physiologically based pharmacokinetic (PBPK) modeling approaches.
    Kato T; Nakagawa H; Mikkaichi T; Miyano T; Matsumoto Y; Ando S
    Eur J Pharm Biopharm; 2020 Jun; 151():45-52. PubMed ID: 32298756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Dissolution as a Tool for Formulation Selection: Telmisartan Two-Step IVIVC.
    Ruiz Picazo A; Martinez-Martinez MT; Colón-Useche S; Iriarte R; Sánchez-Dengra B; González-Álvarez M; García-Arieta A; González-Álvarez I; Bermejo M
    Mol Pharm; 2018 Jun; 15(6):2307-2315. PubMed ID: 29746133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.
    Hasan A; Abul Kalam Azad M; Ullah MA; Mahbub Latif AH; Hasnat A
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):215-21. PubMed ID: 19281731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.